We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CELU market cap is 51.71M. The company's latest EPS is USD -8.7303 and P/E is -1.17.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.94M | 3.79M | 12.11M | 14.68M | 12.11M |
| Operating Income | -127.88M | -99.26M | -10.85M | -7.38M | -10.18M |
| Net Income | -47.95M | -93.88M | 9.55M | -22.01M | -6.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 21.34M | 17.98M | 22.77M |
| Operating Income | -564k | -4.22M | -150.2M | -151.88M | -296.63M |
| Net Income | 2.51M | -2.63M | -100.12M | 14.19M | -196.3M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 246.42M | 157.19M | 143.89M | 143.82M | 135.49M |
| Total Liabilities | 127.92M | 126.95M | 102.93M | 112.57M | 107.68M |
| Total Equity | 118.5M | 30.25M | 40.96M | 31.25M | 27.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 291.61M | 292.16M | 414.13M | 401.07M | 143.89M |
| Total Liabilities | 11.04M | 14.22M | 314.71M | 202.17M | 102.93M |
| Total Equity | 5M | 5M | 99.42M | 198.9M | 40.96M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.02M | -34.34M | -38.69M | -4.4M | -7.85M |
| Investing | -3.24M | -3.47M | -4.05M | -39k | 2.11M |
| Financing | 18.37M | 24.11M | 24.09M | 6.23M | 6.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.1M | -1.18M | -110.1M | -137.88M | -38.69M |
| Investing | -286.85M | 579k | -5.9M | -5.24M | -4.05M |
| Financing | 288.84M | N/A | 98.56M | 119.84M | 24.09M |
| Market Cap | 51.71M |
| Price to Earnings Ratio | -1.17 |
| Price to Sales Ratio | 10.07 |
| Price to Cash Ratio | 1.01k |
| Price to Book Ratio | 5.6 |
| Dividend Yield | - |
| Shares Outstanding | 22.48M |
| Average Volume (1 week) | 45.06k |
| Average Volume (1 Month) | 90.98k |
| 52 Week Change | 18.62% |
| 52 Week High | 7.97 |
| 52 Week Low | 1.30 |
| Spread (Intraday) | 2.45 (71.01%) |
| Company Name | Celularity Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.celularity.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
